VP – People

Posted on 5/8/2024

BigHat Biosciences

BigHat Biosciences

51-200 employees

Develops AI-driven antibody therapeutics

Data & Analytics
AI & Machine Learning


San Mateo, CA, USA

Required Skills
Human Resources Information System (HRIS)
Mergers & Acquisitions (M&A)
Data Analysis
  • Bachelor's degree in a related field
  • Minimum of 10+ years' experience in strategic business partnering, talent development, talent acquisition, organizational development, talent management, total rewards, HRIS, and people operations
  • Experience in biotech, technology, pharmaceutical, or healthcare market
  • Success in developing strategic plans in human resources
  • Experience growing a people function in a fast-growth start-up
  • General understanding of Life Sciences or technology industries
  • Ability to synthesize complex data and communicate effectively
  • Excellent communication and presentation skills
  • Provide thought leadership to the management team
  • Define short-and-long term strategic people plans
  • Implement processes for DEIB and strong culture alignment
  • Drive and maintain efficient human resources infrastructure
  • Coach and mentor the management team
  • Lead workforce planning and strategy
  • Develop organizational design for growth
  • Oversee career paths and levels with total rewards philosophy
  • Prepare and report on compensation and benefits issues
  • Build and oversee employee experience and life cycles
  • Represent employer brand with new and potential employees
  • Ensure compliance with HR regulations and policies
  • Manage performance reviews and employee programs
  • Own HR systems, data, and analytics
  • Establish collaborative and open culture
  • Enhance diversity, equity, inclusion, and belonging
  • Provide guidance on people initiatives
  • Communicate effectively with cross-functional teams

BigHat Biosciences utilizes machine learning and synthetic biology to develop advanced antibody therapeutics, integrating a high-speed wet lab with AI technologies to accelerate the antibody engineering process, potentially driving the development of safer and more effective treatments for challenging diseases.

Company Stage

Series B

Total Funding



San Mateo, California



Growth & Insights

6 month growth


1 year growth


2 year growth